Arypsa Stock

Arypsa Equity

The The Equity of Arypsa (APYI) as of Aug 5, 2026 is 6.79 M USD.

Equity

6.79 MUSD

Last updated:

In 2026, Arypsa's equity was 6.79 M USD, a % increase from the - USD equity in the previous year.

Access this data via the Eulerpool API

Arypsa Stock analysis

What does Arypsa do? Aspyra Inc. is an American company based in California that specializes in the development and distribution of medical IT solutions. The history of Aspyra dates back to 1993 when the company was founded as an independent provider of medical imaging technology. In the following years, Aspyra expanded its business model and focused on developing integrated solutions for the healthcare industry. Today, the company offers a wide range of products and services such as RIS, PACS, LIS, and teleradiology systems that are used by hospitals, clinics, and medical practices worldwide. Aspyra also has specialized divisions within the company that focus on specific solutions. One of these divisions is INSIGHT, which specializes in the development of LIS systems. These solutions provide a specialized software platform that simplifies laboratory management and the workflow of medical tests and results. Another important division of Aspyra is the teleradiology department, which transmits specialized medical imaging findings and reports via telecommunication systems from one radiologist to another. This is particularly advantageous in providing care to patients in rural areas or areas with limited healthcare services. Aspyra also offers various software products, including the PACS system, the Radiology Information System (RIS), and the LIS system. The PACS system allows for the capture of medical images and provides them in electronic form, while the RIS system facilitates the management process of radiology departments and administrative processes related to the data. The LIS system, specifically tailored to the needs of laboratories, also supports the creation of contingency reports and better quality assurance. In recent years, Aspyra has also formed partnerships with other companies in the healthcare industry to expand its product portfolio. This includes a recent collaboration with Healthline Networks and First Databank to combine its IT systems with health data and information from third-party specialists. Aspyra has established itself as a leading provider of medical IT solutions and offers its customers a wide range of products and services. Thanks to its expertise in the healthcare industry, the company has been able to expand its presence in the global market and establish itself as an important partner for medical facilities in North America and Europe. Arypsa is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Arypsa's Equity

Arypsa's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Arypsa's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Arypsa's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Arypsa's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Arypsa’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Arypsa stock

The Equity of Arypsa is 6.79 M USD in 2026.

On Eulerpool you can find the complete historical development of The Equity Arypsa since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Arypsa historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Arypsa

All Key Metrics — Arypsa